These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37245960)

  • 21. N
    Zhang J; Chen Y; Liu C; Li L; Li P
    J Diabetes Res; 2020; 2020():1080152. PubMed ID: 32280711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term obestatin treatment of mice type 2 diabetes increases insulin sensitivity and improves liver function.
    Kołodziejski PA; Pruszyńska-Oszmałek E; Strowski MZ; Nowak KW
    Endocrine; 2017 Jun; 56(3):538-550. PubMed ID: 28477305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic‑induced alterations in hepatic glucose and lipid metabolism: The role of type 1 and type 2 diabetes mellitus (Review).
    Jiang S; Young JL; Wang K; Qian Y; Cai L
    Mol Med Rep; 2020 Aug; 22(2):603-611. PubMed ID: 32468027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Glucotoxicity and lipotoxicity: factors in the pathogenesis and evolution of type 2 diabetes].
    Durruty P; García de los Ríos M
    Rev Med Chil; 2001 Jun; 129(6):671-9. PubMed ID: 11510210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.
    Kotani K; Peroni OD; Minokoshi Y; Boss O; Kahn BB
    J Clin Invest; 2004 Dec; 114(11):1666-75. PubMed ID: 15578099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
    Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMPD2 plays important roles in regulating hepatic glucose and lipid metabolism.
    Yang H; Wang Q; Xi Y; Yu W; Xie D; Morisaki H; Morisaki T; Cheng J
    Mol Cell Endocrinol; 2023 Nov; 577():112039. PubMed ID: 37567359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin K1 inversely correlates with glycemia and insulin resistance in patients with type 2 diabetes (T2D) and positively regulates SIRT1/AMPK pathway of glucose metabolism in liver of T2D mice and hepatocytes cultured in high glucose.
    Dihingia A; Ozah D; Ghosh S; Sarkar A; Baruah PK; Kalita J; Sil PC; Manna P
    J Nutr Biochem; 2018 Feb; 52():103-114. PubMed ID: 29175667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAQR3 regulates phosphorylation of FoxO1 in insulin-resistant HepG2 cells via NF-κB signaling pathway.
    Chen L; Sun X; Xiao H; Xu F; Yang Y; Lin Z; Chen Z; Quan S; Huang H
    Exp Cell Res; 2019 Aug; 381(2):301-310. PubMed ID: 31095939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes.
    Sajan MP; Ivey RA; Lee M; Mastorides S; Jurczak MJ; Samuels VT; Shulman GI; Braun U; Leitges M; Farese RV
    Mol Endocrinol; 2014 Jul; 28(7):1097-107. PubMed ID: 24877563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolites as regulators of insulin sensitivity and metabolism.
    Yang Q; Vijayakumar A; Kahn BB
    Nat Rev Mol Cell Biol; 2018 Oct; 19(10):654-672. PubMed ID: 30104701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of low-carbohydrate diet and ketogenic diet on glucose and lipid metabolism in type 2 diabetic mice.
    Yang Z; Mi J; Wang Y; Xue L; Liu J; Fan M; Zhang D; Wang L; Qian H; Li Y
    Nutrition; 2021 Sep; 89():111230. PubMed ID: 33838492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular mechanisms of insulin resistance in humans.
    Shulman GI
    Am J Cardiol; 1999 Jul; 84(1A):3J-10J. PubMed ID: 10418851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice.
    Lu B; Zhong J; Pan J; Yuan X; Ren M; Jiang L; Yang Y; Zhang G; Liu D; Zhang C
    J Transl Med; 2019 Dec; 17(1):422. PubMed ID: 31847906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity, insulin resistance and hepatic perfusion.
    Brock RW; Dorman RB
    Microcirculation; 2007; 14(4-5):339-47. PubMed ID: 17613806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of type 2 diabetic mellitus animal models via interactions between insulin and mitogen‑activated protein kinase signaling pathways induced by a high fat and sugar diet and streptozotocin.
    Zhuo J; Zeng Q; Cai D; Zeng X; Chen Y; Gan H; Huang X; Yao N; Huang D; Zhang C
    Mol Med Rep; 2018 Apr; 17(4):5132-5142. PubMed ID: 29393432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of selective insulin resistance in isolated hepatocytes.
    Cook JR; Langlet F; Kido Y; Accili D
    J Biol Chem; 2015 May; 290(22):13972-80. PubMed ID: 25873396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.
    Wolfrum C; Asilmaz E; Luca E; Friedman JM; Stoffel M
    Nature; 2004 Dec; 432(7020):1027-32. PubMed ID: 15616563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.